Screening tests: a review with examples

Abstract

Screening tests are widely used in medicine to assess the likelihood that members of a defined population have a particular disease. This article presents an overview of such tests including the definitions of key technical (sensitivity and specificity) and population characteristics necessary to assess the benefits and limitations of such tests. Several examples are used to illustrate calculations, including the characteristics of low dose computed tomography as a lung cancer screen, choice of an optimal PSA cutoff and selection of the population to undergo mammography. The importance of careful consideration of the consequences of both false positives and negatives is highlighted. Receiver operating characteristic curves are explained as is the need to carefully select the population group to be tested.

Cited by papers we hold 5

• Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases · 2023
  No notice
• Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations · 2021
  Not checked
• Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance · 2021
  No notice
• Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients · 2020
  No notice
• Diagnostic accuracy of functional imaging modalities for chondrosarcoma: A systematic review and meta-analysis · 2019
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.